Paul Aisen, MD - Alzheimer's Clinical Trials Consortium

Treating Before Symptoms—ADCS Invites Ideas for Clinical Trials in Very Early AD

Recruitment begins in early Alzheimer's Phase 2 Elayta trial

Paul Aisen - Faculty Member/Professor @ University of California, San Diego - Crunchbase Person Profile

Advancing Alzheimer's Disease Therapies in a Collaborative Science Ecosystem (Section 1) - Alzheimer's Disease Drug Development

RE-ENGINEERING ALZHEIMER CLINICAL TRIALS: GLOBAL ALZHEIMER'S PLATFORM NETWORK • The Journal of Prevention of Alzheimer's Disease

Michael S. Rafii, MD, PhD on LinkedIn: I'm excited to be speaking at the next National Down Syndrome Society…

Diagnostic Criteria & Guidelines

Frontiers Amyloid-β and α-Synuclein Immunotherapy: From Experimental Studies to Clinical Trials

Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease, Alzheimer's Research & Therapy